Ulrike Witt
Hausham, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Shoulder reduction on the scene: current practice and outcome of the Bavarian Mountain Rescue Service-a prospective observational study.
Journal: Scientific reports
Published: May 22, 2023
Prophylactic Anti-Cytomegalovirus Hyperimmunoglobulin in Critically Ill Liver Transplant Patients: Impact on Early Immunology and Survival.
Journal: Journal of clinical medicine
Published: January 31, 2020
The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma.
Journal: Journal of surgical oncology
Published: May 28, 2019
Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma.
Journal: Scientific reports
Published: June 13, 2017
Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: December 09, 2015
Treating ischaemia-reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation.
Journal: Alimentary pharmacology & therapeutics
Published: April 26, 2015
Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients.
Journal: Digestive diseases and sciences
Published: November 26, 2014
Postinterventional tumor necrosis predicts recurrence-free long-term survival in liver transplant patients with advanced hepatocellular carcinoma.
Journal: Transplantation proceedings
Published: December 28, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026